Seventy-five percent of all COVID-19 vaccine trials around the world are using Schott's glass vials, according to the manufacturer. To meet the growing demand, their employees are working around ...

The new method, published in npj Vaccines, analyzes the vaccine vial label and its adhesive and therefore allows the vaccine vials to be retained in the supply chain. Furthermore, the study has ...

MDV: Multidose vial; NA: Not available ... influenza vaccination campaign estimated that the total time to get a vaccine ready to be administered per patient was 87 s for MDVs and 49.71 s for ...

In these cases, the label on the vaccine vial had also been falsified. The Vaccine Identify Evaluation (VIE) Collaboration are developing novel tests for detecting falsified vaccines in supply chains.